Dianthus Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Jun 2017 | — | — | $63.8M |
| Sep 2017 | — | — | $60.0M |
| Dec 2017 | $4.1M | $54.5M | $51.4M |
| Mar 2018 | — | — | $41.5M |
| Jun 2018 | $8.4M | $180.6M | $173.4M |
| Sep 2018 | $13.0M | $172.8M | $159.7M |
| Dec 2018 | $11.7M | $157.3M | $58.3M |
| Mar 2019 | $13.7M | $147.7M | $31.2M |
| Jun 2019 | $15.9M | $195.4M | $33.1M |
| Sep 2019 | $15.7M | $177.2M | $85.5M |
| Dec 2019 | $20.3M | $161.5M | $65.1M |
| Mar 2020 | $19.0M | $144.4M | $74.9M |
| Jun 2020 | $16.8M | $190.7M | $136.3M |
| Sep 2020 | $16.1M | $174.6M | $141.7M |
| Dec 2020 | $17.7M | $161.6M | $58.2M |
| Mar 2021 | $15.6M | $144.6M | $49.3M |
| Jun 2021 | $17.5M | $220.4M | $155.0M |
| Sep 2021 | $16.5M | $206.2M | $157.5M |
| Dec 2021 | $17.3M | $189.9M | $131.7M |
| Mar 2022 | $43.2M | $194.4M | $71.8M |
| Jun 2022 | $39.4M | $175.1M | $54.8M |
| Sep 2022 | $40.1M | $164.1M | $36.9M |
| Dec 2022 | $9.5M | $83.1M | $15.4M |
| Mar 2023 | $6.0M | $83.4M | $23.2M |
| Jun 2023 | $4.0M | $78.6M | $40.3M |
| Sep 2023 | $14.1M | $192.5M | $157.3M |
| Dec 2023 | $10.5M | $179.4M | $132.3M |
| Mar 2024 | $9.8M | $382.5M | $329.7M |
| Jun 2024 | $10.7M | $369.0M | $314.2M |
| Sep 2024 | $16.4M | $354.2M | $33.7M |
| Dec 2024 | $21.5M | $374.0M | $22.8M |
| Mar 2025 | $20.0M | $348.6M | $10.1M |
| Jun 2025 | $23.0M | $326.1M | $13.2M |
| Sep 2025 | $31.0M | $577.4M | $56.0M |
| Dec 2025 | $37.5M | $530.9M | $51.1M |
| Mar 2026 | $45.6M | $1.25B | $627.7M |
| Jun 2026 | $41.2M | $1.21B | $110.5M |